Current
Regulatory and Scientific Issues
in Genetic Toxicology
Invited Speakers Presentations
David
M. DeMarini, Ph.D.
U.S. Environmental Protection Agency, Research
Triangle Park, NC
Vasily N. Dobrovolsky, Ph.D.
NCTR/FDA
Pig-A
Gene - A New Endogenous Target for Detection
of in vivo Mutation Using Flow Cytometry
Rosalie
K. Elespuru
Food and Drug Administration, CDRH
ILSI
and ICH Battery Maintenance: Increased Voltage
or Hazard Identification Short Circuit?
Patricia Escobar, Ph.D.
Boehringer-Ingelheim Pharmaceuticals, Inc.
New
Applications of the Comet Assay in Genetic Toxicology
Testing
Sheila M. Galloway, Ph.D.
Merck Research Laboratories, West Point, PA
Elmar Gocke, Ph.D.
F. Hoffmann-La Roche Ltd
Risk
Assessment of Genotoxic Impurities: The Case
of EMS
B. Bhaskar Gollapudi, Ph.D.
The Dow Chemical Company
David
Jacobson-Kram, Ph.D., D.A.B.T.
OND, CDER, FDA
Changes
to ICH S2: Why They Are Needed, How They Will
Help
Michelle O. Kenyon
Pfizer Global Research and Development
Risk
Management Strategies for Ames Mutagens
Channa
Keshava, Ph.D.
National Center for Environmental Assessment,
Office of Research and Development
U.S. Environmental Protection Agency
Use
of Genotoxicity Data in Mode of Action Analysis
for Human Health Risk Assessment
Dan
D. Levy, Ph.D.
Food and Drug Administration, CFSAN
What
Makes an In Vitro Positive Irrelevant?
A Case Study with Eugenol
James T. MacGregor, Ph.D., D.A.B.T.
Toxicology Consulting Services
Genetic
Toxicology Assessment: Balancing Regulation
and Science
Martha
Moore, Ph.D.
US-FDA, NCTR
Overview
of the Latest Recommendations for Interpreting
Data from the Mouse Lymphoma Assay
Paul Nioi, Ph.D.
The Schering-Plough Research Institute
Prediction
of Non-Genotoxic Carcinogenesis in Rats Using
Changes in Gene Expression Following Acute Dosing
James F. Rusling, Ph.D.
University of Connecticut
Chemistry Department
Electro-optical
Toxicity Screening Arrays and Complementary
Biocolloid LC-MS Method